aspartic acid has been researched along with losartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, YH; Husain, A; Karnik, SS; Liu, XP; Noda, K; Saad, Y | 1 |
| Hunyady, L; Kersemans, V; Le, MT; Szaszák, M; Vanderheyden, PM; Vauquelin, G | 1 |
2 other study(ies) available for aspartic acid and losartan
| Article | Year |
|---|---|
The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arginine; Aspartic Acid; Binding Sites; Biphenyl Compounds; Imidazoles; Inositol Phosphates; Losartan; Models, Molecular; Protein Binding; Receptors, Angiotensin; Structure-Activity Relationship; Tetrazoles | 1995 |
Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Antihypertensive Agents; Aspartic Acid; Benzimidazoles; Biphenyl Compounds; CHO Cells; Cricetinae; Humans; Imidazoles; Kinetics; Losartan; Mutagenesis, Site-Directed; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Transfection; Tritium | 2003 |